Moderna falls on fears new CDC vaccine advisory panel could cloud RSV shot prospects

• click to rate

  Posted by Two Blokes Jun 13 - Filed in Stock - 5 views
  
  Moderna's shares fell 2.5% before the bell on Friday, on concerns whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group.